Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
The PR Week: 5.7.2026 - Courtney Kasinger, Eli Lilly and Company
Courtney Kasinger, senior communications leader at Eli Lilly, serves as jury chair for the 2026 PRWeek Healthcare Awards. In a recent podcast she highlighted the most inspiring campaigns, the rise of influencer partnerships, and how data‑driven storytelling is reshaping pharma marketing. Kasinger also noted regulatory shifts that demand greater transparency and patient‑centric messaging. Her insights reflect broader industry movement toward digital engagement and ethical influence.
Signs You Might Need a Root Canal Based on Symptoms
The American Dental Association’s 2023 guidelines report that prompt root‑canal therapy saves over 95% of infected teeth, yet many patients delay care because they mistake the pain for a routine toothache. Persistent, throbbing pain that worsens at night, prolonged temperature...
Radiologists Speak Out Against Whole-Body MRI Screening in Prominent Editorial
Two leading radiologists published a JAMA editorial urging consumers to skip elective whole‑body MRI scans, noting that over 100,000 people have already paid for the service despite no major medical society endorsing it for the general population. They argue the...
Join Us in May for HTN Now and Hear From Inspiring Panellists Sharing Their Insights, Projects, Learnings, and Perspectives
HTN is hosting a free online webinar series for NHS professionals in May, featuring three panels on AI in primary care (13 May), the NHS 10‑year health plan (19 May), and the digital patient journey (20 May). Each session brings together senior clinicians,...
What Impact Could Protein Stabilisation Have for Cancer Patients?
In this episode of the DDW Podcast, CEO Anthony Johnson and CSO Matthew Fyfe discuss OutRun Therapeutics' novel protein‑stabilisation platform, which inhibits specific E3 ubiquitin ligases to prevent degradation of disease‑relevant proteins. Their lead program targets the E6AP ligase to...
Epic Founder and CEO Judy Faulkner Shares Insights on 50 Year Journey in YouTube Interview
Epic founder and CEO Judy Faulkner reflected on the company’s near‑50‑year evolution in electronic health records during a YouTube interview with Katie Couric. She traced her early coding days, the shift from paper charts to digital systems, and how being a...
New IP Rider Rules Could Lower Premiums Despite Rising Private Healthcare Costs, MOH Says
Singapore’s Ministry of Health (MOH) announced that policyholders who switch to the newly revised Integrated Shield Plan (IP) rider framework can expect premium reductions of 35% to 40%, despite a backdrop of rising private‑hospital IP costs. Between 2021 and 2024,...
Free Rabies Care in India Highlights US Cost Crisis
A German tourist was bitten by a stray dog in Surat. He rushed to a local govt hospital. The final bill for his complete rabies treatment? ₹0 He posted about it and it went viral. He was shocked by how fast, clean, and free...
NHS Scotland Notes Intent to Explore Options for Multi-Channel Remote Health Monitoring Solution
NHS Scotland has issued a prior information notice to explore a multi‑channel remote health monitoring and communication solution, with a formal contract notice slated for July 2026. The agency is conducting a soft market test, asking suppliers to complete a questionnaire...
Halozyme and Oruka Sign Agreement for Hypercon Technology
Halozyme’s Hypercon technology has entered an exclusive global licensing agreement with Oruka Therapeutics to develop ORKA-001, a biologic targeting the IL‑23p19 subunit for psoriasis and related inflammatory diseases. The deal provides Halozyme with an upfront cash payment, future milestone fees,...
Global Drugmakers Eye More China Biotech Deals After Record Year
Global pharmaceutical firms are intensifying their pursuit of Chinese biotech partners after 2025 set a record $135.7 billion in out‑licensing deals, nearly three times the 2024 total. Executives from Johnson & Johnson and Merck highlighted plans to expand on‑the‑ground resources and...
Xtant Medical Launches Trivium Shaped Allograft for Surgeries
US‑based Xtant Medical has commercially launched Trivium Shaped, a pre‑shaped allograft that joins its Trivium bone‑graft portfolio. The product is supplied in ready‑to‑use boats and strips, leveraging PureLoc technology to produce uniform cortical fibers within a composite of cancellous bone and...
Don’t Bury The Lead – AI Assisted Measures of Thymic Health Point to a “Fountain of Youth.”
A Nature paper introduced an AI deep‑learning system that reads CT scans to produce a continuous "thymic health" score for adults. Applying the model to 27,612 participants revealed that higher thymic health is associated with lower rates of cardiovascular disease,...
Fibrosis, IPF and the Search for Better Therapies
The BioSpace "Denatured" podcast episode spotlights the persistent challenges of idiopathic pulmonary fibrosis (IPF) and broader fibrotic diseases. Host Jennifer C. Smith‑Parker interviews Georg Vo Beiske, CEO of Tribune Therapeutics, and Jonas Hallén, CMO of Calluna Pharma, to dissect current treatment gaps and...
Macrophage‐Inspired Nanomedicines: Harnessing Innate Biology for Precision Therapy
The review outlines macrophage‑inspired nanomedicines that exploit three delivery platforms—whole macrophage carriers, macrophage‑membrane‑coated nanoparticles, and macrophage‑derived exosomes. By leveraging the cells’ natural homing, barrier‑penetrating and immunomodulatory traits, these systems aim to improve targeting of cancers, atherosclerosis and other inflammatory diseases....
Beyond the Clinic: A Blueprint For Developing Reliable, Edge AI-Enabled Medical Devices
Edge‑AI‑enabled home ultrasound devices are being piloted to bring diagnostic imaging to remote patients. Pulsenmore, using Synaptics Astra embedded processors, embeds real‑time AI guidance that alerts users on probe placement, speed, and gel usage, producing clinically usable scans in minutes...
Inside FDP – Part 2: Delivering on the NHS Vision for Data
The NHS’s Frontline Data Platform (FDP) shifts from a reporting‑first model to a Frontline‑First approach, embedding data tools directly into clinical workflows. By leveraging Palantir Foundry’s low‑code environment, trusts can build and deploy applications such as Optica, cutting discharge delays...
The Evolution of Shared Care Records – From Documents to Conversations
Shared Care Records (SCRs) have progressed from simple document‑exchange hubs to intelligent, conversational platforms that actively assist clinicians and patients. The first generation offered read‑only PDFs, while the second introduced structured, longitudinal data that could be queried and updated across...
AI in Psychiatry Becomes Future Standard, Not Optional
I was the first patient I know of who had AI used during a patient session with a psychiatrist. The video of our interview for my show is up here somewhere. She told me it will soon be malpractice to...
Shaping the Future of Health and Connected Care
The UKAuthority virtual conference returns next week to unite NHS, local government and social‑care leaders around integrated, neighbourhood‑based care. With the NHS 10‑year plan now in delivery, the event will explore three shifts: moving services from hospital to community, adopting...
ISO 25553 to Deliver Smart Multigenerational Neighbourhoods
ISO 25553, titled Smart Multigenerational Neighbourhoods, was unveiled at the Agile Ageing Alliance’s 10th‑anniversary Leaders Forum in London on 12 May. The new international standard offers a shared framework for aligning health, social care, housing, digital infrastructure and community services at the...
Trends From the Trenches: The Capability Jump of AI and Its Impact
AI’s rapid capability jump is reshaping computational biology, especially bioinformatics pipelines such as RNA‑seq, single‑cell and spatial transcriptomics. While software firms report most code now AI‑assisted, biotech teams still write code manually, creating a clear adoption gap. Benchmarks—capability, task and...
Oncology Care Ignores Patient Survival vs QoL Preferences
"Patient preference for extending survival or maintaining QoL was not associated with up-front treatment modifications or downstream outcomes, suggesting a possible lack of responsiveness of the current oncology care delivery system to patient preference." https://t.co/0RXf4h2dr3 In: Outcomes of Older Adults With Advanced...
UPDATE ON THE BIGGEST VACCINE MANDATE CASE
Jayden Beale’s human‑rights lawsuit against Queensland’s COVID‑19 vaccine mandates has survived a critical QCAT hearing, where the judge rejected the government’s attempt to dismiss the case and criticized its lack of evidence. The case, potentially the largest of its kind...
Diagnosed With IgA Nephropathy? Ask Your Doctor These Questions
The article equips newly diagnosed IgA nephropathy patients with a checklist of essential questions for their next doctor visit. It emphasizes reviewing kidney‑biopsy results, confirming the nephrologist’s glomerular‑disease expertise, and understanding the full care team composition. It also guides patients...
Planning for the Future With IgA Nephropathy
IgA nephropathy (IgAN) progresses differently for each patient, with proteinuria, hematuria and eGFR trends serving as the primary prognostic markers. Dr. Salem Almaani emphasizes proactive planning—especially around pregnancy, infection prevention, and potential dialysis or transplant needs—as key to managing uncertainty....
As Vaccine Rejectionism Spreads, Measles May Be Taking a More Dangerous Turn
Measles cases are resurging globally as vaccine hesitancy fuels new outbreaks. The CDC recorded 2,285 confirmed cases in 2025 and 1,575 by March 2026 across 31 U.S. states, while Australia, Indonesia, India and several other countries report rising incidence. Experts...
Can a Private Company Drag the NHS Toward Prevention?
Neko, a UK‑based preventive‑health startup, argues that the NHS’s chronic under‑investment in prevention can only be reversed by a consumer‑pull model, not by policy alone. Founder Hjalmar Nilsonne likens the approach to Spotify’s disruption of piracy and climate‑tech’s shift from...
Handle with Care: Chinese Study Finds Aquatic Virus Can Infect Human Eyes
Chinese researchers have identified the covert mortality nodavirus (CMNV), a pathogen long known in shrimp, as the cause of a newly described eye disease, persistent ocular hypertensive viral anterior uveitis (POH‑VAU), in humans. The study, published in Nature Microbiology, linked...
Beverages Expected to Play Larger Role in Supporting GLP-1 Community
A November 2025 Kaiser Family Foundation poll shows 12% of U.S. adults are currently taking GLP‑1 drugs such as Ozempic or Wegovy, and 27% of households have at least one member on the medication. Adoption is highest among women and...
Age Well Neighbourhood Initiative to Be Rolled Out to Three More Areas as Singapore Hits Super-Aged Status
Singapore, now classified as super‑aged with over 21% of citizens 65+, is expanding its Age Well Neighbourhood programme to three additional towns—Bedok, Bukit Panjang and Tiong Bahru‑Redhill. The rollout adds senior‑friendly infrastructure, enhanced community health posts, and home personal care that will...
Humid Heat May Increase the Risk of Premature Birth. But Aspirin Could Help
New research published in JAMA Network Open finds that pregnant women exposed to humid heat have a higher likelihood of preterm birth, with each 1 °C increase in temperature raising risk by about 5%. In a randomized trial of over 11,500...
Doctors Spend Double Time on Paperwork, Not Patients
You didn't study 10 years to become a data entry operator. But here you are. 9pm. Still charting. Dinner cold. Family asleep. For every 1 hour with your patient — the system demands 2 hours of paperwork. Nobody told you this in medical college. Because...
REPORT: The WHO Is Pushing a New Cruise Ship “Outbreak” Scare, and the Same PCR-Driven Fear Machine That Shut Down...
The World Health Organization recently issued an alert about a possible global spread of hantavirus, a rodent‑borne disease that rarely transmits between humans. The announcement relies heavily on PCR test results, a method that sparked controversy during the COVID‑19 pandemic...
WA Biotech Duo Takes Aim at Diabetes Beyond Ozempic
Australian biotech duo ProGenis Pharmaceuticals and Syngenis Labs are developing RNA‑based antisense therapies that target insulin resistance, a root cause of type‑2 diabetes, to complement GLP‑1 drugs. Syngenis is building Australia’s first GMP‑grade synthetic DNA/RNA manufacturing facility, expected to be...
Should You Ask ChatGPT for Medical Advice?
A recent interview with Harvard assistant professor Adam Rodman examines the surge of AI chatbots like ChatGPT as sources of medical advice. While 68% of U.S. adults have turned to search engines for health information, about a third of those users...
Japan's TMS-007 Shows Promise for Stroke Treatment
@ej23ny @BiotechXGuru @biotech_cash @Ceazar_Black Anyone here look at Japan Biotech? I'm far from an expert, but I think 4891.T (TMS) is worth looking into. Its a nano cap with dilutive equity warrants (and a smallish cash runway) but their main...
The Latest News in Vaccine Obstruction
Large-scale safety studies of COVID‑19 and shingles vaccines, analyzing millions of records, found rare serious side effects, but the FDA blocked their publication citing unsupported conclusions. The agency also refused to file Moderna’s mRNA flu‑COVID combo vaccine, despite European approval...
PYC Therapeutics Advances PKD Program with Phase 1b Multiple Ascending Dose Study Initiation
PYC Therapeutics has dosed the first patient in a Phase 1b multiple‑ascending‑dose (MAD) study of its PKD candidate PYC‑003, targeting safety, tolerability and early efficacy signals such as urinary PC1 protein, total kidney volume and eGFR. Results from the earlier Phase 1a...
The Universal Health Coverage Clock Is Ticking: Lessons From Egypt’s Journey Toward Universal Health Insurance
Egypt’s Universal Health Insurance (UHI) law, enacted in 2018, created a three‑tier architecture that separates financing, service delivery, and accreditation. The Universal Health Insurance Authority now finances a benefit package covering over 3,500 services and 4,900 medicines, while an independent...
We Still Lack Basic Outbreak Protocols After COVID
It’s kind of wild to me that even after Covid, we really have no idea what to during a disease outbreak. It’s like there are no protocols or policies and we just wing it. “people are getting sick with a deadly...
Unfunded $24B Could Have Delivered 100‑Day Prototype Vaccines
Every so often I think about how, in 2022, for $24B we could had "prototype vaccines ready for each of the 26 known viral families that cause human disease" so they can be deployed in 100 days if there was...
The Peptide Problem: Hype Is Outrunning the Evidence
Health Canada has warned Canadians against buying and injecting unauthorized peptide products such as BPC‑157, CJC‑1295, ipamorelin, TB‑500 and retatrutide, and has already seized several shipments. Influencers on Instagram and TikTok are promoting these compounds for anti‑aging, weight loss and...
Andes Hantavirus Sparks Complex Public‑Health Challenge
Hantavirus outbreaks rarely happen. This Andes strain is ‘a complicated public-health situation.’ @jaimy_lee reports https://t.co/Tqqt7pODWB via @MarketWatch
Tiny BCI Chip Delivers High‑Bandwidth Wireless Neural Links
Ultra-Compact Brain–Computer Interface Chip Enables High-Bandwidth Wireless Neural Communication by @CUSEAS #MedTech #Healthcare #HealthTech #Tech #Technology https://t.co/nWSUX4xCRz
Catheter Producer Rests Defense in Product Liability, Negligence Trial
A federal bellwether trial in Phoenix is testing liability for more than 3,000 claims that C.R. Bard’s PowerPort catheter caused infections. Plaintiff Robert Cook’s expert argues the sepsis arose during at‑home de‑access of the port, not during surgical implantation, shifting...
Early Adversity Predicts Later Functional Decline and Multimorbidity
Adverse childhood and adult experiences, intrinsic capacity decline, and subsequent physical-psychological-cognitive multimorbidity: a prospective cohort study from China "Childhood adversity is associated with reduced intrinsic capacity in later life, reflecting early functional vulnerability, while both childhood and adulthood adversities contribute to...
Healthcare Providers Rethink Operations and Real Estate Amid Financial Strain
Healthcare providers are currently struggling with a challenging financial environment, forcing them to rethink their operational and real estate strategies.
New Liver Replacement: Prime Strategy for Aging Liver
The best treatment for aging liver is the new liver. Replacement is a viable long-term therapeutic and longevity strategy. Great insights from the replacement workshop organized by Sierra Lore and team as part of @ARDD_Meeting https://t.co/xYFQ9Fy2Jc https://t.co/ipQfpxcRNq
Hospital CEO Vows to Replace Radiologists with AI
CEO of America’s largest public hospital system says he’s ready to replace radiologists with #AI by Marty Stempniak @RadiologyBiz Learn more: https://t.co/8sUQb2B5gz #MedTech #Healthcare #HealthTech #Tech #TechForGood https://t.co/GpaBWUwzko